Ogawara Ken-ichi | Department Of Pharmaceutics Faculty Of Pharmaceutical Sciences Okayama University
スポンサーリンク
概要
- OGAWARA Ken-ichiの詳細を見る
- 同名の論文著者
- Department Of Pharmaceutics Faculty Of Pharmaceutical Sciences Okayama Universityの論文著者
関連著者
-
Ogawara Ken-ichi
Department Of Pharmaceutics Faculty Of Pharmaceutical Sciences Okayama University
-
HIGAKI Kazutaka
Department of Basic Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyoto University
-
Kimura Toshikiro
Department Of Pharmaceutics Faculty Of Pharmaceutical Sciences Okayama University
-
Higashi Yutaka
Department Of Pharmaceutics Institute Of Pharmaceutical Sciences Hiroshima University School Of Medi
-
OGAWARA Ken-ichi
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University
-
Higaki Kazutaka
Okayama Univ. Graduate School Of Medicine Dentistry And Pharmaceutical Sci.
-
Sakane Toshiyasu
Department of Biopharmaceutics, Kyoto Pharmaceutical University
-
Katsumi Hidemasa
Department Of Biopharmaceutics Kyoto Pharmaceutical University
-
Furubayashi Tomoyuki
Department of Pharmaceutics, School of Pharmacy, Shujitsu University
-
Yamamoto Akira
Department Of Anatomy School Of Medicine University Of Tokushima
-
INOUE Daisuke
Department of Electronic Science and Engineering, Kyoto University
-
KIMURA Toshikiro
Department of Pharmaceutics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceu
-
KATSUMI Hidemasa
Department of Biopharmaceutics, Kyoto Pharmaceutical University
-
KONO Yusuke
Division of Earth Rotation, National Astronomical Observatory
-
MUKAI Tadashi
Formulation Research Institute, Otsuka Pharmaceutical Co., Ltd.
-
ODOMI Masaaki
Formulation Research Institute, Otsuka Pharmaceutical Co., Ltd.
-
Ono Tsutomu
Department Of Chemical Engineering Faculty Of Engineering Kyushu University
-
Kamada Naoki
Formulation Development 1 Formulation Research Institute Otsuka Pharmaceutical Co. Ltd.
-
Odomi Masaaki
Formulation Development 1 Formulation Research Institute Otsuka Pharmaceutical Co. Ltd.
-
Oka Yoshikazu
Formulation Development 1 Formulation Research Institute Otsuka Pharmaceutical Co. Ltd.
-
MIYAKE Masateru
Formulation Development 1, Formulation Research Institute, Otsuka Pharmaceutical Co., Ltd.
-
MINAMI Takanori
Histopathology Research Office, Department of Toxicology, Tokushima Research Institute, Otsuka Pharm
-
YAMAZAKI Hiroyuki
Formulation Development 1, Formulation Research Institute, Otsuka Pharmaceutical Co., Ltd.
-
KATO Yusuke
Formulation Development 1, Formulation Research Institute, Otsuka Pharmaceutical Co., Ltd.
-
TOGUCHI Hajime
Formulation Development 1, Formulation Research Institute, Otsuka Pharmaceutical Co., Ltd.
-
Toguchi Hajime
Formulation Development 1 Formulation Research Institute Otsuka Pharmaceutical Co. Ltd.
-
Ogawara Ken-ichi
Division Of Pharmaceutical Sciences Graduate School Of Medicine Dentistry And Pharmaceutical Science
-
Miyake Masateru
Formulation Development 1 Formulation Research Institute Otsuka Pharmaceutical Co. Ltd.
-
Minami Takanori
Histopathology Research Office Department Of Toxicology Tokushima Research Institute Otsuka Pharmace
-
Higaki Kazutaka
Division Of Pharmaceutical Sciences Graduate School Of Medicine Dentistry And Pharmaceutical Science
-
Mukai Tadashi
Formulation Research Institute Otsuka Pharmaceutical Co. Ltd.
-
KADONO Keitaro
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University
-
YOKOE Jun-ichi
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University
-
Kato Yusuke
Formulation Development 1 Formulation Research Institute Otsuka Pharmaceutical Co. Ltd.
-
Kadono Keitaro
Department Of Pharmaceutics Faculty Of Pharmaceutical Sciences Okayama University
-
Yokoe Jun-ichi
Department Of Pharmaceutics Faculty Of Pharmaceutical Sciences Okayama University
-
Yamamoto Akira
Department Of Anatomy School Of Medicine University Of Tokushuma
-
Yamazaki Hiroyuki
Department Of Pharmacokinetics And Biopharmaceutics Subdivision Of Biopharmaceutical Sciences Instit
-
Inoue Daisuke
Department Of I. M. S. E. Kagawa University
-
Kimura Shunsuke
Department of Biopharmaceutics, Kyoto Pharmaceutical University
-
Naruse Mamoru
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University
-
Konishi Ryoji
Formulation Development Department, Teikoku Seiyaku Co., Ltd.
-
Araki Tomoya
Division of Pharmaceutical Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
-
Watanabe Takaichi
Department of Material and Energy Science, Graduate School of Environmental Science, Okayama University
-
Kimura Toshikiro
Division of Pharmaceutical Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
-
Tanaka Akiko
Department Of Cardiovascular Surgery Himeji Cardiovascular Center
-
HIGAKI Kazutaka
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University
-
Kono Yusuke
Division of Pharmaceutical Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
-
Ono Tsutomu
Department of Material and Energy Science, Graduate School of Environmental Science, Okayama University
-
Higashi Yutaka
Department of Pharmaceutics, School of Pharmacy, Shujitsu University
-
Higaki Kazutaka
Division of Pharmaceutical Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
-
Inoue Daisuke
Department of Pharmaceutics, School of Pharmacy, Shujitsu University
-
Shingaki Tomotaka
RIKEN Center for Molecular Imaging Science
-
Yoshizawa Yuta
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University
-
Un Keita
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University
-
Araki Tomoya
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University
-
Tanaka Akiko
Department of Biopharmaceutics, Kyoto Pharmaceutical University
-
SONE Miki
Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Okayama University
著作論文
- Optimization of Suppository Preparation Containing Sodium Laurate and Taurine That Can Safely Improve Rectal Absorption of Rebamipide(Biopharmacy)
- Analysis and Prediction of Absorption Behavior for Theophylline Orally Administered as Powders Based on Gasrtointestinal-transit-Absorption (Gita) Model
- In Vitro Evaluation of Nasal Mucociliary Clearance Using Excised Rat Nasal Septum
- Development of Transdermal Therapeutic Formulation of CNS5161, a Novel N-Methyl-D-aspartate Receptor Antagonist, by Utilizing Pressure-Sensitive Adhesives I
- Formulation and Evaluation of Paclitaxel-Loaded Polymeric Nanoparticles Composed of Polyethylene Glycol and Polylactic Acid Block Copolymer
- In Vitro Evaluation of the Ciliary Beat Frequency of the Rat Nasal Epithelium Using a High-Speed Digital Imaging System
- Nanoparticle-Based Passive Drug Targeting to Tumors: Considerations and Implications for Optimization
- Regulation of Drug Absorption from Small Intestine by Enteric Nervous System I : a Poorly Absorbable Drug Via Passive Diffusion